|Articles|January 15, 2020
Catalent Launches FlexDirect
Advertisement
Catalent has announced the launch of FlexDirect, a new direct-to-patient service for clinical trials. The FlexDirect service provides sponsors with the choice of site-to-patient distribution, or Catalent’s new pharmacy-to-patient service.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
How Community Sites Can Stay Competitive Under Growing Efficiency Pressures
3
Moving Beyond Historical Site Data to Real-Time Patient Insight
4
The Challenges of Buying Blind: Why Providing the Clinical Outcome Assessment Measure Prior to License Execution Would Significantly Benefit Clinical Trial Set-Up
5